Ikarian Capital, LLC Orchard Therapeutics PLC Transaction History

Ikarian Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.42 - $0.78 $65,354 - $121,372	-155,606 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$0.7 - $1.51 $5,232 - $11,287	7,475 Added 5.05%	155,606 $110,000
Q3 2021 Nov 15, 2021	SELL	$2.24 - $4.29 $4,186 - $8,018	-1,869 Reduced 1.25%	148,131 $341,000
Q2 2021 Aug 16, 2021	SELL	$4.39 - $7.23 $438,999 - $723,000	-100,000 Reduced 40.0%	150,000 $659,000
Q1 2021 May 17, 2021	BUY	$4.39 - $9.08 $1.1 Million - $2.27 Million	250,000 New	250,000 $1.82 Million

545K

Ticker ORTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,458,000
Description
Orchard Therapeutics plc, a biopharmaceutical company, develops gene therapies for serious and life-threatening rare diseases in the United Kingdom, European Union, and the United States. The company's gene therapy approach seeks to transform a patient's hematopoietic stem cells into a gene-modified cellular drug product to treat the patient's d...

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Ikarian Capital, LLC with notifications on news.